Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

NEDA status in highly active MS can be more easily obtained with autologous hematopoietic stem cell transplantation than other drugs.
Modelling the Impact of Persistence Improvements with an Electronic Injection Device on Escalation to 2nd Line Treatment in Patients with Relapsing Remitting Multiple Sclerosis (RRMS).
Do evoked potentials contribute to the functional follow-up and clinical prognosis of multiple sclerosis?
Evaluation of Disability Progression as an Endpoint in Clinical Trials for Relapsing-Remitting Multiple Sclerosis (RRMS): Comparison of the Define and Confirm Studies.
A Real-World Assessment of Annual Multiple Sclerosis Prevalence and Disease-Modifying Drug Treatment Rates Using an Administrative Claims Database.
Cost-Effectiveness of Subcutaneous Verse Intramuscular Interferon Beta-1A In Portugal Based on the Findings of Cochrane Collaboration Review of First-Line Treatments for Relapsing-Remitting Multiple Sclerosis.
The Indirect Costs of Multiple Sclerosis Associated With Absenteeism In Poland.
Susac's syndrome: Leptomeningeal enhancement on 3D FLAIR MRI.
Cross-disease transcriptomics: Unique IL-17A signaling in psoriasis lesions and an autoimmune PBMC signature.
A comparison of multiple sclerosis clinical disease activity between patients treated with natalizumab and fingolimod.
Best Practices and Key Challenges in Cost-Effectiveness Modelling of Multiple Sclerosis Therapies.
Histamine and Immune Biomarkers in CNS Disorders.
Quality of Life Among Patients with Multiple Sclerosis Treated with Prolonged-Release Fampridine 10 Mg Tablets for Walking Impairment.
Cortical functional modifications following optic neuritis.
Biotinidase deficiency mimicking neuromyelitis optica beginning at the age of 4: A treatable disease.
Olfactory dysfunction in patients with multiple sclerosis.
Multiple sclerosis patients lacking oligoclonal bands in the cerebrospinal fluid have less global and regional brain atrophy.
Pharmacoeconomic Aspects of Multiple Sclerosis Treatments in Iran.
Does Current Portuguese Financing Model for Multiple Sclerosis Covers for Estimated Needs?
Sunshine, Sea, and Season of Birth: MS Incidence in Wales.
Extra-Gastrointestinal Manifestations of Inflammatory Bowel Disease May Be Less Common Than Previously Reported.
Astrocyte tissue factor controls CNS hemostasis and autoimmune inflammation.
Further Understanding of the Immunopathology of Multiple Sclerosis: Impact on Future Treatments.
25 Hydroxyvitamin D and Cytokines in Multiple Sclerosis.
Co-stimulatory and Co-inhibitory Pathways in Autoimmunity.

Pages